ArticleFrontiers in immunology2022
Effective low-dose Anlotinib induces long-term tumor vascular normalization and improves anti-PD-1 therapy.
Peng Fan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
28 papers cite it
this papertrialcites it